Seasonal Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Seasonal Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SAR [NA]
A completed trial evaluated the efficacy and safety of levocetirizine given 8 weeks before and after the grass pollen season in adults with …
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic Rhinitis [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of levocetirizine and fexofenadine in reducing symptoms of seasonal allergi…
-
CLINICAL_TRIALS research · 2013-11-20Clinical Trial Update: Effect of a Probiotic on Seasonal Allergic Rhinitis Symptoms [NA]
A Nestlé SPN-sponsored clinical trial evaluated the effect of a probiotic on symptoms of seasonal allergic rhinitis and has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Rhinitis, Cognition and Driving Performance [NA]
A Maastricht University Medical Center study on seasonal allergic rhinitis and its effects on cognition and driving performance has complete…
-
FDA approval · 2013-10-18FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Allegra-D Allergy and Congestion, the combo of fexofenadine hydrochloride and pseudoephedrine hy…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-10-16Clinical Trial Update: Fexofenadine HCL - Pseudoephedrine HCL Combination Versus Allegra in Patients With Seasonal Allergic Rhinitis [Phase 3]
Phase 3 trial comparing fexofenadine HCl–pseudoephedrine HCl versus Allegra (fexofenadine) for seasonal allergic rhinitis has completed.
-
FDA approval · 2013-09-04FDA Approved: CAREONE ALLERGY RELIEF — Supplemental Application (American Sales Company)
FDA approved a supplemental application for CAREONE ALLERGY RELIEF (fexofenadine HCl) from American Sales Company; this pertains to the supp…
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: A Single and Multiple Dose Study to Explore the Safety of JNJ-38224342 in Healthy Patients and Patients With Seasonal Allergies [Phase 1]
This Phase 1 trial update reports the completion of a single- and multiple-dose study assessing the safety of JNJ-38224342 in healthy volunt…
-
CLINICAL_TRIALS trial_result · 2013-09-02Clinical Trial Update: A Study To Investigate If MRI Scanning Is Effective At Seeing What Hayfever Drugs Do In Nasal Passage.
GlaxoSmithKline sponsored a completed study using MRI to observe the effects of hayfever medications on the nasal passages in seasonal aller…
-
FDA approval · 2013-08-20FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental ANDA from Lannett Company to market a generic montelukast sodium product. Montelukast is used in the managem…
-
FDA approval · 2013-08-14FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Montelukast sodium from Torrent Pharmaceuticals Limited, formalizing approval of this generic mo…
-
CLINICAL_TRIALS trial_result · 2013-07-17Clinical Trial Update: Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms [Phase 4]
Phase 4 study assessing the effect of combining Veramyst nasal spray with olopatadine 0.2% ophthalmic solution for allergy symptoms in seaso…
-
CLINICAL_TRIALS trial_result · 2013-07-12Clinical Trial Update: Immune-modulatory Effect of Probiotic Strain on Grass Pollen Allergic Individuals [NA]
A completed clinical trial evaluating the immune-modulatory effect of a Nestlé probiotic strain in individuals with grass pollen–induced sea…
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: Study of rBet v1 Tablets [Phase 2]
A Phase 2 trial of rBet v1 tablets for birch pollen–related allergic conditions has completed.
-
FDA approval · 2013-06-26FDA Approved: MONTELUKAST — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Montelukast by Sandoz Inc., indicating approval of a change to this generic Montelukast product.…
-
CLINICAL_TRIALS trial_result · 2013-06-03Clinical Trial Update: Intranasal Steroids and the Nasal Ocular Response [Phase 4]
This update reports results from a Phase 4 trial examining the nasal-ocular response to intranasal steroids in seasonal allergic rhinitis. T…
-
CLINICAL_TRIALS trial_result · 2013-05-07Clinical Trial Update: A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis [Phase 4]
A randomized, placebo-controlled Phase 4 trial evaluated the efficacy and speed of a Bayer nasal spray in allergen-induced seasonal allergic…
-
FDA approval · 2013-04-29FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare Inc.'s supplemental application for Montelukast Sodium (ANDA 202717). This action confirms approval of a supp…
-
CLINICAL_TRIALS trial_result · 2013-04-19Clinical Trial Update: Efficacy and Safety of Nasal Filters on Seasonal Allergic Rhinitis (Hay Fever) [NA]
Completed clinical trial evaluating the efficacy and safety of nasal filters for seasonal allergic rhinitis.
-
FDA approval · 2013-03-26FDA Approved: DYMISTA — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for DYMISTA (azelastine hydrochloride and fluticasone propionate) filed by Viatris Specialty LLC…
-
CLINICAL_TRIALS trial_result · 2013-03-22Clinical Trial Update: A Study of Onset of Action of Loratadine and Fexofenadine in Participants With Seasonal Allergic Rhinitis (P08712) [Phase 4]
Phase 4 study comparing the onset of action of loratadine and fexofenadine in participants with seasonal allergic rhinitis; the trial is com…
-
FDA approval · 2013-03-21FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC, resulting in changes to the product lab…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: POLlinosis and Exhaled Breath Temperature [Phase 4]
Phase 4 clinical trial update related to pollinosis (seasonal pollen allergy) and exhaled breath temperature.
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhinitis [Phase 4]
This Phase 4 clinical trial compares the effects of montelukast and cetirizine on allergic inflammation in children with seasonal allergic r…
-
FDA approval · 2013-02-05FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental abbreviated new drug application for Montelukast Sodium from Dr. Reddy's Laboratories Limited, expanding generic…